Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125666424 | 12566642 | 4 | F | 201607 | 20160831 | 20160718 | 20160908 | EXP | US-UNITED THERAPEUTICS-UNT-2016-011220 | UNITED THERAPEUTICS | 68.04 | YR | F | Y | 70.30000 | KG | 20160908 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125666424 | 12566642 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 18-54 ?G, QID | 2100812 | 22387 | INHALATION GAS | |||||||||
125666424 | 12566642 | 2 | C | ADEMPAS | RIOCIGUAT | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125666424 | 12566642 | 1 | Pulmonary arterial hypertension |
125666424 | 12566642 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125666424 | 12566642 | HO |
125666424 | 12566642 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125666424 | 12566642 | Anaphylactic reaction | |
125666424 | 12566642 | Dyspnoea | |
125666424 | 12566642 | Hypotension | |
125666424 | 12566642 | Loss of consciousness | |
125666424 | 12566642 | Respiratory arrest |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125666424 | 12566642 | 1 | 20160706 | 201607 | 0 |